Medical Manager (acting Director Medical Affairs from Aug-Oct 2016)
@
Mologen AG (MGN)
5 free lookups per month.
No credit card required.
Marco Giannecchini's Location
Berlin, Berlin, Germany
Marco Giannecchini's Work
Country Medical Lead - Germany - for Epidyolex (Cannabidiol) at Syneos Health (representing GW) @ Syneos Health (Previously INC Research/inVentiv Health)
Interim Manager (Consultant) @ UPGRADE YOUR STRATEGY, Founder and CEO
Director Medical Affairs - Germany @ DEMECAN
Medical Manager (acting Director Medical Affairs from Aug-Oct 2016) @ Mologen AG (MGN)
Interim Medical Manager in Medical Affairs @ MOLOGEN, SHIRE, MEDA, ALLERGAN
Senior Customer Liaison Manager, BU Specialty Medicine (Germany), Neurology and Immunology @ Bayer Pharmaceuticals
International HR Manager, Management Development and Recruitment @ Bayer Pharmaceuticals
Senior Medical Affairs Advisor (EU, Russia, South Africa, Australia and New Zealand) @ Bayer Pharmaceuticals
Scientific Associate and International Medical Affairs Trainee @ Bayer Pharmaceuticals
Traineeship in the department of neurology and psychiatry @ Vivantes Klinikum Neukölln
Marco Giannecchini's Education
University of Pisa
Doctor of Medicine (MD), Medicine
1979 - 1986
Marco Giannecchini's Skills
Oncology
Clinical Research
Biotechnology
Clinical Development
Medical Affairs
Training
KOL managment
scientific data/literature review
CNS disorders
presenting/publishing scientific data
Marco Giannecchini's Summary
Marco Giannecchini, based in Berlin, Berlin, Germany, is currently a Medical Manager (acting Director Medical Affairs from Aug-Oct 2016) at Mologen AG (MGN), bringing experience from previous roles at Syneos Health (Previously INC Research/inVentiv Health), UPGRADE YOUR STRATEGY, Founder and CEO, DEMECAN and MOLOGEN, SHIRE, MEDA, ALLERGAN. Marco Giannecchini holds a 1979 - 1986 Doctor of Medicine (MD), Medicine @ University of Pisa. With a robust skill set that includes Oncology, Clinical Research, Biotechnology, Clinical Development, Medical Affairs and more, Marco Giannecchini contributes valuable insights to the industry.